Select Page

 

Agenda at a Glance

Note: Agenda Subject to Change
Wednesday, October 29, 2025
Time Session Speaker
  3:00-5:00 PM   Registration & Poster Set-Up
  5:00-5:15 PM   Introduction & Greetings from PRF

Audrey Gordon, Esq.
Executive Director
The Progeria Research Foundation

Scott Berns, MD, MPH, FAAP
Board Chair
The Progeria Research Foundation

Leslie Gordon, MD, PhD
Medical Director
The Progeria Research Foundation

  5:15-5:25 PM PRF Medical Research Remarks Leslie Gordon
  5:25-6:25 PM   “Coming of Age” Conversations:  Young Adults with HGPS as Research Partners Moderator: Merlin Waldron, USA
Kaylee Halko, USA
Amber Vandeweert-Wielemans, Belgium
Michiel Vandeweert, Belgium
Riccardo Zanolli, Italy
  6:25-6:35 PM   Musical Kickoff Francis Collins, MD, PhD
  6:35-6:45 PM   Group Photo – All Attendees!
  6:30 PM   Dinner & Collaborative Interaction Time
Thursday, October 30, 2025
  7:45 AM-8:00 PM Registration Desk Open
  8:00-9:00 AM Bridging the Bench Mentor Session
  9:00-9:30 AM Breakfast
 Current Treatment Trial Outcomes in Progeria       Moderator: Mark Kieran, MD, PhD, VP Clinical Development, Day One Biopharmaceuticals
  9:30-9:50 AM New Trial: Disease Progression in Progeria Leslie Gordon, MD, PhD
  9:55-10:15 AM Phase 2a Progerinin in Clinical Treatment Trial for Progeria Monica Kleinman, MD
Boston Children’s Hospital Harvard Medical School
 10:20-10:40 AM Tools for Pivotal Science and Medicine in Progeria: Biomarker Assay Development, Qualification and Reagent Generation Barbara Natke, PhD
Chief Business Officer and Biomarker Lead
The Progeria Research Foundation
 10:45-11:05 AM Late-Stage Treatment of Aortic Stenosis in HGPS Ashwin Prakash, MD
Pediatric Cardiologist
Boston Children’s Hospital
 11:10-11:30 AM Break
 11:35-11:50 AM Late Breaking Presentation: A novel progerin-producing nonclassic HGPS phenotype:  What progeria might look like with effective therapy Linda Bulmer, MD
Sahlgrenska University Hospital
Gothenburg, Sweden
 11:55 AM-12:20 PM Poster Lightning Round Poster Presenters
 12:20-1:30 PM Lunch and Collaborative Interaction Time
Cardiovascular Disease in HGPS and Aging       Moderator: Maria Eriksson, PhD, Professor, Karolinska Institute
 1:30 -1:50 PM New Autoptical Pathological findings Revealing HGPS Pathophysiology Andrea Porzionato, PhD
Professor
University of Padova
 1:55-2:15 PM Single-cell Analysis Reveals the Phenotypic Landscape of Arterial Cells in Progeria Maria Eriksson, PhD
Lara Garcia Merino, MSc
 2:20-2:40 PM Evaluation of Coronary Artery and Aortic Calcium in Progeria by Computed Tomography Sunil Ghelani, MD
Attending Cardiologist
Boston Children’s Hospital 
 2:45-3:05 PM Angiopoietin-2: A Potential Therapeutic Target for Vascular Protection in Hutchinson-Gilford Progeria Syndrome Lizzy Izydore, BS  (for Kan Cao, PhD)
University of Maryland
 3:05-3:25 PM Break
 3:25-3:45 PM Bridging the gap: Translating CVpathology to clinical assessments and research study design Keri Shafer, MD & Sheila Hegde, MD
UT Southwestern Medical Center 
 3:50-4:10 PM Progeria and Vascular Calcification: Diet and Treatments Ricardo Villa Bellosta, PhD
Group Leader, Ramon y Cajal Researcher
Center for Research in Molecular Medicine and Chronic Diseases
 4:15-4:25 PM Poster Elevation – LRRK2 Knockdown Rescues Progerin-Induced Premature Aging Lukas Mann
Institute of Molecular Biology Mainz, Germany
 4:25-4:35 PM Poster Elevation – National Interview Survey for Patients with Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies and Their Families in Japan Yuko Okawa, MD
Oita University, Japan
 4:35 -5:30 PM Break Adjourn Until Poster Session & Dinner
 5:30-6:30 PM Poster Session Part 1 Even Numbered Posters
 6:00-7:00 PM Dinner and Collaborative Interaction Time
 7:00-8:00 PM Poster Session Part 2   Odd Numbered Posters

 

Friday, October 31, 2025
  7:30 AM-2:00 PM Registration Desk Open
  7:30-8:30 AM Breakfast & Networking
Progeria Treatment Discovery for a Healthy Future      Moderator: Leslie Gordon
  8:30-8:50 AM AI-driven Therapeutic Antisense Oligonucleotide for HGPS Ning Shen, PhD
Professor
Liangzhu Laboratory, Zhejiang University School of Medicine
  8:55-9:15 AM Development of Gene Silencing (RNAi) and Gene Editing Therapeutics for Hutchinson-Gilford Progeria Syndrome (HGPS) Nizar Saad, PhD
Abigail Wexner Research Institute, Nationwide Children’s Hospital 
  9:20-9:45 AM Mini Plenary: Cutting Edge Translational Gene Therapy David Liu, PhD
Thomas Dudley Cabot Professor of the Natural Sciences
Howard Hughes Medical Institute Investigator
Harvard University
Broad Institute
 9:50-10:10 AM ProSPER: PROgeria Streamlined Platform Gene Editing for Rare Diseases David Liu
Francis Collins
Leslie Gordon
Meirui An, PhD, Broad Institute
Mike Erdos, PhD, NHGRI 
 10:15-10:35 AM First-Generation PROTACs for Improving Progeria Phenotype Silvia Ortega Gutierrez, PhD
Professor
Universidad Complutense de Madrid
 10:35-10:55 AM Break
Endocrine and GI Disease in Progeria       Moderator: Vicente Andrés, PhD, Professor, Centro Nacional de Investigaciones Cardiovasculares Carlos III
 10:55-11:15 AM Lipodistrophy and Cardiovascular Pathology in HGPS Vicente Andrés
 11:20-11:40 AM Unraveling Accelerated Intestinal Ageing in HGPS Physiopathology: An Integrative Approach Laurence Arbibe, MD, PhD
Director
INSERM Institut Necker Enfants Malades
 11:45-12:05 PM Targeting Inflammation to Ameliorate HGPS Pathologies Susana Gonzalo, PhD
Professor
St. Louis University School of Medicine
 12:15-1:00 PM Workshop Summary Session All Hands Discussion Leslie Gordon and Francis Collins

2025 PRF International Scientific Workshop Scientific Committee

Leslie B. Gordon, MD, PhD (Chair) Medical Director, The Progeria Research Foundation; Professor of Pediatrics, Hasbro Children’s Hospital, Boston Children’s Hospital, and Harvard Medical School 

Vicente Andres, PhD Professor, Centro Nacional de Investigaciones Cardiovasculares Carlos III

Maria Eriksson, PhDProfessor, Karolinska Institute

Mark Kieran, MD, PhD – VP Clinical Development, Day One Biopharmaceuticals

2025 PRF International Scientific Workshop Planning Committee

Leslie B. Gordon, MD, PhD (Chair) – Medical Director, The Progeria Research Foundation; Professor of Pediatrics, Hasbro Children’s Hospital, Boston Children’s Hospital, and Harvard Medical School 

Audrey Gordon, Esq – President and Executive Director, The Progeria Research Foundation

Gina Incrovato – Director of Operations, The Progeria Research Foundation                                               

Darrien Marazzo – Clinical Trial Coordinator, The Progeria Research Foundation 

Karen Gordon BetournaySocial Media and Website Coordinator, The Progeria Research Foundation

Elizabeth Maynard Elizabeth Maynard, CMP, Meeting Planner, Etre Partners

en_USEnglish